SCHEMBL22019776

SCHEMBL22019776

CCc1c(C2CC2)nc2c(c1C)CCC2

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.33
GAA P10253 2/20 0.33
CYP1A2 P05177 1/20 0.33
POLB P06746 3/20 0.33
TSHR P16473 3/20 0.33
L3MBTL1 Q9Y468 2/20 0.33
MAPK1 P28482 2/20 0.33
ALDH1A1 P00352 1/20 0.33
NPC1 O15118 1/20 0.32
RAB9A P51151 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
MAPT P10636 1/20 0.32
CRHR1 P34998 1/20 0.32
ACHE P22303 5/20 0.32
MEN1 O00255 3/20 0.32
KMT2A Q03164 3/20 0.32
BPTF Q12830 1/20 0.32
ALPL P05186 1/20 0.32
ALPI P09923 1/20 0.32
ALPG P10696 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24978158 0.87 GAA (0.38) KDM4EGAACYP1A2POLBTSHR
SCHEMBL24979083 0.83 ACHE (0.46) KDM4ECYP1A2TSHRMAPK1ALDH1A1
SCHEMBL30162178 0.83 ACHE (0.46) KDM4ECYP1A2TSHRMAPK1ALDH1A1
SCHEMBL22019706 0.81 KDM4E (0.38) KDM4ECYP1A2MAPK1ALDH1A1NPC1
SCHEMBL22019725 0.81 CYP1A2 (0.33) KDM4EGAACYP1A2POLBTSHR
SCHEMBL22020006 0.80 TSHR (0.34) KDM4EGAACYP1A2POLBTSHR
SCHEMBL24977971 0.80 CYP1A2 (0.31) KDM4EGAACYP1A2POLBTSHR
SCHEMBL22020067 0.78 KDM4E (0.36) KDM4ECYP1A2MAPK1ALDH1A1ACHE
SCHEMBL22019707 0.76 KDM4E (0.37) KDM4EGAACYP1A2MAPK1ALDH1A1
SCHEMBL22019959 0.74 NPSR1 (0.36) KDM4ETSHRMAPK1CRHR1ACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020102096-A1 COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY NOVARTIS INFLAMMASOME RESEARCH, INC. (US) 2020-05-22 WO disclosed